Simple gel may shield cancer patients from debilitating Hand-Foot rash
NCT ID NCT07177560
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 32 times
Summary
This study looked at whether applying a diclofenac gel to the hands and feet can prevent or delay hand-foot syndrome—a painful skin reaction—in people with colorectal or stomach cancer taking the chemotherapy drug capecitabine. About 150 patients were observed, with some using the gel and others just monitored. The goal was to see if the gel reduces severe skin problems and helps patients stay on their cancer treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ankara Etlik City Hospital
Ankara, Turkey (Türkiye)
-
Gazi University
Ankara, Turkey (Türkiye)
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.